id,sequence,label,elisa_flags,source
abituzumab,QVQLQQSGGELAKPGASVKVSCKASMHWVRQAPGQGLEWIGYEYNEIFRDKATMTTDTSTSTAYMELSSLRSEDTAVYYCWGQGTTVTVSSDIQMTQSPSSLSASVGDRVTITCRASLAWYQQKPGKAPKLLIYKIHSGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
abrilumab,QVQLVQSGAEVKKPGASVKVSCKVSIHWVRQAPGKGLEWMGGIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCWGQGTLVTVSSDIQMTQSPSSVSASVGDRVTITCRASLAWYQQKPGKAPKLLIYNLESGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCFGQGTKVEIK,0.0,0,jain2017_pnas
adalimumab,EVQLVESGGGLVQPGRSLRLSCAASMHWVRQAPGKGLEWVSADYADSVEGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRASLAWYQQKPGKAPKLLIYTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
alemtuzumab,QVQLQESGPGLVRPSQTLSLTCTVSMNWVRQPPGRGLEWIGFEYNPSVKGRVTMLVDTSKNQFSLRLSSVTAADTAVYYCWGQGSLVTVSSDIQMTQSPSSLSASVGDRVTITCKASLNWYQQKPGKAPKLLIYNLQTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
alirocumab,EVQLVESGGGLVQPGGSLRLSCAASMNWVRQAPGKGLDWVSTNYADSVKGRFIISRDSSKHTLYLQMNSLRAEDTAVYYCWGRGTLVTVSSDIVMTQSPDSLAVSLGERATINCKSSLGWYQQKPGQPPNLLIYTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCFGQGTKLEIK,0.0,0,jain2017_pnas
anifrolumab,EVQLVQSGAEVKKPGESLKISCKGSIAWVRQMPGKGLESMGIRYSPSFQGQVTISADKSITTAYLQWSSLKASDTAMYYCWGRGTLVTVSSEIVLTQSPGTLSLSPGERATLSCRASFAWYQQKPGQAPRLLIYSRATGIPDRLSGSGSGTDFTLTITRLEPEDFAVYYCFGQGTRLEIK,0.0,0,jain2017_pnas
atezolizumab,EVQLVESGGGLVQPGGSLRLSCAASIHWVRQAPGKGLEWVAWYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRASVAWYQQKPGKAPKLLIYFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
bapineuzumab,EVQLLESGGGLVQPGGSLRLSCAASMSWVRQAPGKGLEWVASYYSDNVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCWGQGTLVTVSSDVVMTQSPLSLPVTPGEPASISCKSSLNWLLQKPGQSPQRLIYKLDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFGQGTKVEIK,0.0,0,jain2017_pnas
basiliximab,QVQLQQSGTVLARPGASVKMSCKASMHWIKQRPGQGLEWIGASYNQKFEGKAKLTAVTSASTAYMELSSLTHEDSAVYYCWGQGTTLTVSSQIVSTQSPAIMSASPGEKVTMTCSASMQWYQQKPGTSPKRWIYKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCFGGGTKLEIK,0.0,0,jain2017_pnas
bavituximab,EVQLQQSGPELEKPGASVKLSCKASMNWVKQSHGKSLEWIGHSYNQKFRGKATLTVDKSSSTAYMQLKSLTSEDSAVYYCWGAGTTVTVSSDIQMTQSPSSLSASLGERVSLTCRASLNWLQQGPDGTIKRLIYSLDSGVPKRFSGSRSGSDYSLTISSLESEDFVDYYCFGAGTKLELK,0.0,0,jain2017_pnas
belimumab,QVQLQQSGAEVKKPGSSVRVSCKASINWVRQAPGQGLEWMGGKYSQNFQGRVAITADESTGTASMELSSLRSEDTAVYYCWGRGTMVTVSSSSELTQDPAVSVALGQTVRVTCQGDASWYQQKPGQAPVLVIYNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCFGGGTELTVL,1.0,6,jain2017_pnas
benralizumab,EVQLVQSGAEVKKPGASVKVSCKASIHWVRQRPGQGLAWMGYKYNERFKGKVTITSDRSTSTVYMELSSLRSEDTAVYLCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCGTSLNWYQQKPGKAPKLLIYRLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
bevacizumab,EVQLVESGGGLVQPGGSLRLSCAASMNWVRQAPGKGLEWVGWTYAADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCSASLNWYQQKPGKAPKVLIYSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
bimagrumab,QVQLVQSGAEVKKPGASVKVSCKASINWVRQAPGQGLEWMGTSYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCWGQGTLVTVSSQSALTQPASVSGSPGQSITISCTGTVNWYQQHPGKAPKLMIYKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCFGGGTKLTVL,0.0,0,jain2017_pnas
blosozumab,QVQLVQSGAEVKKPGASVKVSCKVSQHWVRQAPGKGLEWMGWEYASKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCWGQGTTVTVSSDIQMTQSPSSLSASVGDRVTITCKASVAWYQQKPGKAPKLLIYTRWTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGGGTKVEIK,1.0,6,jain2017_pnas
bococizumab,QVQLVQSGAEVKKPGASVKVSCKASMHWVRQAPGQGLEWMGENYNEKFKSRVTMTRDTSTSTVYMELSSLRSEDTAVYYCWGQGTTVTVSSDIQMTQSPSSLSASVGDRVTITCRASLAWYQQKPGKAPKLLIYYRYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCFGQGTKLEIK,1.0,6,jain2017_pnas
brentuximab,QIQLQQSGPEVVKPGASVKISCKASITWVKQKPGQGLEWIGWKYNEKFKGKATLTVDTSSSTAFMQLSSLTSEDTAVYFCWGQGTQVTVSADIVLTQSPASLAVSLGQRATISCKASMNWYQQKPGQPPKVLIYNLESGIPARFSGSGSGTDFTLNIHPVEEEDAATYYCFGGGTKLEIK,,3,jain2017_pnas
briakinumab,QVQLVESGGGVVQPGRSLRLSCAASMHWVRQAPGKGLEWVAFYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCWGQGTMVTVSSQSVLTQPPSVSGAPGQRVTISCSGSVKWYQQLPGTAPKLLIYQRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCFGTGTKVTVL,1.0,4,jain2017_pnas
brodalumab,QVQLVQSGAEVKKPGASVKVSCKASISWVRQAPGQGLEWMGWNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCWGQGTLVTVSSEIVMTQSPATLSVSPGERATLSCRASLAWFQQKPGQAPRPLIYTRATGVPARFSGSGSGTDFTLTISSLQSEDFAVYYCFGGGTKVEIK,,1,jain2017_pnas
canakinumab,QVQLVESGGGVVQPGRSLRLSCAASMNWVRQAPGKGLEWVAIYYADSVKGRFTISRDNSKNTLYLQMNGLRAEDTAVYYCWGQGTLVTVSSEIVLTQSPDFQSVTPKEKVTITCRASLHWYQQKPDQSPKLLIKQSFSGVPSRFSGSGSGTDFTLTINSLEAEDAAAYYCFGPGTKVDIK,0.0,0,jain2017_pnas
carlumab,QVQLVQSGAEVKKPGSSVKVSCKASISWVRQAPGQGLEWMGGNYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCWGQGTLVTVSSEIVLTQSPATLSLSPGERATLSCRASLAWYQQKPGQAPRLLIYSRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCFGQGTKVEIK,1.0,4,jain2017_pnas
certolizumab,EVQLVESGGGLVQPGGSLRLSCAASMNWVRQAPGKGLEWMGWIYADSVKGRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCKASVAWYQQKPGKAPKALIYFLYSGVPYRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
cetuximab,QVQLKQSGPGLVQPSQSLSITCTVSVHWVRQSPGKGLEWLGVDYNTPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYCWGQGTLVTVSADILLTQSPVILSVSPGERVSFSCRASIHWYQQRTNGSPRLLIKESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCFGAGTKLELK,0.0,0,jain2017_pnas
cixutumumab,EVQLVQSGAEVKKPGSSVKVSCKASISWVRQAPGQGLEWMGGNYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCWGKGTTVTVSSSSELTQDPAVSVALGQTVRITCQGDATWYQQKPGQAPILVIYKRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCFGGGTKLTVL,1.0,6,jain2017_pnas
clazakizumab,EVQLVESGGGLVQPGGSLRLSCAASVTWVRQAPGKGLEWVGIAYATSAIGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCWGQGTLVTVSSAIQMTQSPSSLSASVGDRVTITCQASLSWYQQKPGKAPKLLIYTLASGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCFGGGTKVEIK,0.0,0,jain2017_pnas
codrituzumab,QVQLVQSGAEVKKPGASVKVSCKASMHWVRQAPGQGLEWMGAAYSQKFKGRVTLTADKSTSTAYMELSSLTSEDTAVYYCWGQGTLVTVSSDVVMTQSPLSLPVTPGEPASISCRSSLHWYLQKPGQSPQLLIYNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFGQGTKLEIK,1.0,6,jain2017_pnas
crenezumab,EVQLVESGGGLVQPGGSLRLSCAASMSWVRQAPGKGLELVASYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCWGQGTTVTVSSDIVMTQSPLSLPVTPGEPASISCRSSLHWYLQKPGQSPQLLIYNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFGQGTKVEIK,0.0,0,jain2017_pnas
dacetuzumab,EVQLVESGGGLVQPGGSLRLSCAASIHWVRQAPGKGLEWVARSYNQKFKGRFTLSVDNSKNTAYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRSSLHWYQQKPGKAPKLLIYNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYFCFGQGTKVEIK,0.0,0,jain2017_pnas
daclizumab,QVQLVQSGAEVKKPGSSVKVSCKASMHWVRQAPGQGLEWIGYEYNQKFKDKATITADESTNTAYMELSSLRSEDTAVYYCWGQGTLVTVSSDIQMTQSPSTLSASVGDRVTITCSASMHWYQQKPGKAPKLLIYNLASGVPARFSGSGSGTEFTLTISSLQPDDFATYYCFGQGTKVEVK,,1,jain2017_pnas
dalotuzumab,QVQLQESGPGLVKPSETLSLTCTVSWNWIRQPPGKGLEWIGYNYKPSLKDRVTISRDTSKNQFSLKLSSVTAADTAVYYCWGQGTLVTVSSDIVMTQSPLSLPVTPGEPASISCRSSLQWYLQKPGQSPQLLIYNRLYGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFGQGTKVEIK,1.0,5,jain2017_pnas
daratumumab,EVQLLESGGGLVQPGGSLRLSCAVSMSWVRQAPGKGLEWVSAYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCWGQGTLVTVSSEIVLTQSPATLSLSPGERATLSCRASLAWYQQKPGQAPRLLIYNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCFGQGTKVEIK,0.0,0,jain2017_pnas
denosumab,EVQLLESGGGLVQPGGSLRLSCAASMSWVRQAPGKGLEWVSGYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCWGQGTLVTVSSEIVLTQSPGTLSLSPGERATLSCRASLAWYQQKPGQAPRLLIYSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVFYCFGQGTKVEIK,1.0,5,jain2017_pnas
dinutuximab,EVQLLQSGPELEKPGASVMISCKASMNWVRQNIGKSLEWIGASYNQKFKGRATLTVDKSSSTAYMHLKSLTSEDSAVYYCWGQGTSVTVSSEIVMTQSPATLSVSPGERATLSCRSSLHWYLQKPGQSPKLLIHNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCFGAGTKLELK,0.0,0,jain2017_pnas
drozitumab,EVQLVQSGGGVERPGGSLRLSCAASMSWVRQAPGKGLEWVSGGYADSVKGRVTISRDNAKNSLYLQMNSLRAEDTAVYYCWGKGTTVTVSSSELTQDPAVSVALGQTVRITCSGDASWYQQKPGQAPVLVIYNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCFGGGTKLTVL,0.0,0,jain2017_pnas
duligotuzumab,EVQLVESGGGLVQPGGSLRLSCAASIHWVRQAPGKGLEWVGEDYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRASVAWYQQKPGKAPKLLIYFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKVEIK,1.0,6,jain2017_pnas
dupilumab,EVQLVESGGGLEQPGGSLRLSCAGSMTWVRQAPGKGLEWVSSYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCWGQGTTVTVSSDIVMTQSPLSLPVTPGEPASISCRSSLDWYLQKSGQSPQLLIYNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGFYYCFGQGTKLEIK,1.0,5,jain2017_pnas
eculizumab,QVQLVQSGAEVKKPGASVKVSCKASIQWVRQAPGQGLEWMGEEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCGASLNWYQQKPGKAPKLLIYNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
efalizumab,EVQLVESGGGLVQPGGSLRLSCAASMNWVRQAPGKGLEWVGMRYNQKFKDRFTISVDKSKNTLYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRASLAWYQQKPGKAPKLLIYTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
eldelumab,QMQLVESGGGVVQPGRSLRLSCTASMHWVRQAPGKGLEWVAVFYVDSVKGRFTISRDNSKNTLYLEMNSLRAEDTAIYYCWGQGTTVTVSSEIVLTQSPGTLSLSPGERATLSCRASLAWYQQKPGQAPRLLIYSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCFGPGTKVDIK,0.0,0,jain2017_pnas
elotuzumab,EVQLVESGGGLVQPGGSLRLSCAASMSWVRQAPGKGLEWIGENYAPSLKDKFIISRDNAKNSLYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCKASVAWYQQKPGKVPKLLIYTRHTGVPDRFSGSGSGTDFTLTISSLQPEDVATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
emibetuzumab,QVQLVQSGAEVKKPGASVKVSCKASMHWVRQAPGQGLEWMGRTYNQKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCWGQGTTVTVSSDIQMTQSPSSLSASVGDRVTITCSVSLHWYQQKPGKAPKLLIYNLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGGGTKVEIK,1.0,6,jain2017_pnas
enokizumab,QVQLVQSGAEVKKPGSSVKVSCKASIEWVRQAPGQGLEWMGENPNEKFKGRVTITADESTSTAYMELSSLRSEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCKASVTWYQQKPGKAPKLLIYYSYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGGGTKVEIK,0.0,0,jain2017_pnas
epratuzumab,QVQLVQSGAEVKKPGSSVKVSCKASLHWVRQAPGQGLEWIGYEYNQNFKDKATITADESTNTAYMELSSLRSEDTAFYFCWGQGTTVTVSSDIQLTQSPSSLSASVGDRVTMSCKSSLAWYQQKPGKAPKLLIYTRESGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCFGGGTKLEIK,,1,jain2017_pnas
etrolizumab,EVQLVESGGGLVQPGGSLRLSCAASWGWVRQAPGKGLEWVGYSYNPSLKSRFTISRDTSKNTFYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRASLHWYQQKPGKAPKLLIKQSISGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKVEIK,,2,jain2017_pnas
evolocumab,EVQLVQSGAEVKKPGASVKVSCKASISWVRQAPGQGLEWMGWNYAQKLQGRGTMTTDPSTSTAYMELRSLRSDDTAVYYCWGQGTTVTVSSESALTQPASVSGSPGQSITISCTGTVSWYQQHPGKAPKLMIYNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCFGGGTKLTVL,,2,jain2017_pnas
farletuzumab,EVQLVESGGGVVQPGRSLRLSCSASLSWVRQAPGKGLEWVAMYYADSVKGRFAISRDNAKNTLFLQMDSLRPEDTGVYFCWGQGTPVTVSSDIQLTQSPSSLSASVGDRVTITCSVSLHWYQQKPGKAPKPWIYNLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
fasinumab,QVQLVQSGAEVKKPGASVKVSCKVSIHWVRQAPGKGLEWMGGIYAQKFQGRVTMTEDTSTDTAYMELTSLRSEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASAGDRVTITCRASLGWYQQKPGKAPKRLIYNLQSGVPSRFSGSGSGTEFTLTISSLQPEDLASYYCFGQGTKVEIK,0.0,0,jain2017_pnas
fezakinumab,QVQLVQSGAEVKKPGASVKVSCKASMHWVRQAPGQGLEWVGWFYAQKFRGRVTMTRDTSISTAYMELSRLRSDDTAVYYCWGRGTLVTVSSQAVLTQPPSVSGAPGQRVTISCTGSVHWYQQLPGTAPKLLIYNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCFGGGTQLTVL,0.0,0,jain2017_pnas
ficlatuzumab,QVQLVQPGAEVKKPGTSVKLSCKASMHWVRQAPGQGLEWIGENYNQKFQGRATLTVDKSTSTAYMELSSLRSEDTAVYYCWGQGTLLTVSSDIVMTQSPDSLAMSLGERVTLNCKASVSWYQQKPGQSPKLLIYNRESGVPDRFSGSGSATDFTLTISSVQAEDVADYHCFGQGTKLEIK,0.0,0,jain2017_pnas
figitumumab,EVQLLESGGGLVQPGGSLRLSCTASMNWVRQAPGKGLEWVSAFYADSVKGRFTISRDNSRTTLYLQMNSLRAEDTAVYYCWGQGTTVTVSSDIQMTQFPSSLSASVGDRVTITCRASLGWYQQKPGKAPKRLIYRLHRGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCFGQGTKLEIK,,3,jain2017_pnas
fletikumab,QVQLVQSGAEVKRPGASVKVSCKASIHWVRQAPGQRLEWMGWQYSQNFQDRVSITRDTSASTAYMELISLRSEDTAVYYCWGQGTTVTVSSAIQLTQSPSSLSASVGDRVTITCRASLAWYQQKPGKAPKLLIYSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGGGTKVEIK,0.0,0,jain2017_pnas
foralumab,QVQLVESGGGVVQPGRSLRLSCAASMHWVRQAPGKGLEWVAVYYVDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCWGRGTLVTVSSEIVLTQSPATLSLSPGERATLSCRASLAWYQQKPGQAPRLLIYNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCFGGGTKVEIK,,2,jain2017_pnas
fresolimumab,QVQLVQSGAEVKKPGSSVKVSCKASISWVRQAPGQGLEWMGGNYAQRFKGRVTITADESTSTTYMELSSLRSEDTAVYYCWGQGTLVTVSSETVLTQSPGTLSLSPGERATLSCRASLAWYQQKPGQAPRLLIYSRAPGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCFGQGTRLEIK,0.0,0,jain2017_pnas
fulranumab,EVQLVESGGGLVQPGGSLRLSCAASMNWVRQAPGKGLEWVSYFYADSVKGRFTISRDNAKNSLYLQMDSLRDEDTAMYYCWGQGILVTVSSAIQLTQSPSSLSASVGDRVTITCRASLAWYQQKPGKAPKLLIYSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGGGTKVEIK,,1,jain2017_pnas
galiximab,QVQLQESGPGLVKPSETLSLTCAVSWGWIRQPPGKGLEWIGSYYNPSLKSQVTISTDTSKNQFSLKLNSMTAADTAVYYCWGPGVLVTVSSESALTQPPSVSGAPGQKVTISCTGSLHWYQQLPGTAPKLLIYKRPSGISDRFSGSKSGTAASLAITGLQTEDEADYYCFGGGTRLTVL,0.0,0,jain2017_pnas
ganitumab,QVQLQESGPGLVKPSGTLSLTCAVSWSWVRQPPGKGLEWIGENYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCWGQGTMVTVSSDVVMTQSPLSLPVTPGEPASISCRSSLDWYLQKPGQSPQLLIYNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFGQGTKVEIK,0.0,0,jain2017_pnas
gantenerumab,QVELVESGGGLVQPGGSLRLSCAASMSWVRQAPGKGLEWVSAYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIVLTQSPATLSLSPGERATLSCRASLAWYQQKPGQAPRLLIYSRATGVPARFSGSGSGTDFTLTISSLEPEDFATYYCFGQGTKVEIK,1.0,6,jain2017_pnas
gemtuzumab,EVQLVQSGAEVKKPGSSVKVSCKASIHWVRQAPGQSLEWIGYDYNQKFKNRATLTVDNPTNTAYMELSSLRSEDTAFYYCWGQGTLVTVSSDIQLTQSPSTLSASVGDRVTITCRASLTWFQQKPGKAPKLLMYNQGSGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCFGQGTKVEVK,0.0,0,jain2017_pnas
gevokizumab,QVQLQESGPGLVKPSQTLSLTCSFSVGWIRQPSGKGLEWLAHSYNPSLKSRLTISKDTSKNQVSLKITSVTAADTAVYFCWGQGTLVTVSSDIQMTQSTSSLSASVGDRVTITCRASLSWYQQKPGKAVKLLIYKLHSGVPSRFSGSGSGTDYTLTISSLQQEDFATYFCFGQGTKLEIK,0.0,0,jain2017_pnas
girentuximab,DVKLVESGGGLVKLGGSLKLSCAASMSWVRQTPEKRLELVAAYYLDTVKGRFTISRDNAKNTLYLQMSSLKSEDTALFYCWGQGTSVTVSSDIVMTQSQRFMSTTVGDRVSITCKASVAWYQQKPGQSPKLLIYNRYTGVPDRFTGSGSGTDFTLTISNMQSEDLADFFCFGGGTKLEIK,0.0,0,jain2017_pnas
glembatumumab,QVQLQESGPGLVKPSQTLSLTCTVSWSWIRHHPGKGLEWIGYYSNPSLKSRVTISVDTSKNQFSLTLSSVTAADTAVYYCWGQGTLVTVSSEIVMTQSPATLSVSPGERATLSCRASLVWYQQKPGQAPRLLIYTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCFGQGTKVEIK,0.0,0,jain2017_pnas
golimumab,QVQLVESGGGVVQPGRSLRLSCAASMHWVRQAPGNGLEWVAFKYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCWGQGTTVTVSSEIVLTQSPATLSLSPGERATLSCRASLAWYQQKPGQAPRLLIYNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCFGPGTKVDIK,,1,jain2017_pnas
guselkumab,EVQLVQSGAEVKKPGESLKISCKGSIGWVRQMPGKGLEWMGIRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCWGQGTLVTVSSQSVLTQPPSVSGAPGQRVTISCTGSVHWYQQLPGTAPKLLIYKRPSGVPDRFSGSKSGTSASLAITGLQSEDEADYYCFGGGTKLTVL,,1,jain2017_pnas
ibalizumab,QVQLQQSGPEVVKPGASVKMSCKASIHWVRQKPGQGLDWIGYDYDEKFKGKATLTSDTSTSTAYMELSSLRSEDTAVYYCWGQGTLVTVSSDIVMTQSPDSLAVSLGERVTMNCKSSLAWYQQKPGQSPKLLIYTRESGVPDRFSGSGSGTDFTLTISSVQAEDVAVYYCFGGGTKLEIK,0.0,0,jain2017_pnas
imgatuzumab,QVQLVQSGAEVKKPGSSVKVSCKASIHWVRQAPGQGLEWMGYTYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCWGQGTTVTVSSDIQMTQSPSSLSASVGDRVTITCRASLNWYQQKPGKAPKRLIYNLQTGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCFGQGTKLEIK,1.0,5,jain2017_pnas
infliximab,EVKLEESGGGLVQPGGSMKLSCVASMNWVRQSPEKGLEWVAEHYAESVKGRFTISRDDSKSAVYLQMTDLRTEDTGVYYCWGQGTTLTVSSDILLTQSPAILSVSPGERVSFSCRASIHWYQQRTNGSPRLLIKESMSGIPSRFSGSGSGTDFTLSINTVESEDIADYYCFGSGTNLEVK,0.0,0,jain2017_pnas
inotuzumab,EVQLVQSGAEVKKPGASVKVSCKASIHWVRQAPGQGLEWIGGTYRRKFQGRVTMTADTSTSTVYMELSSLRSEDTAVYYCWGQGTLVTVSSDVQVTQSPSSLSASVGDRVTITCRSSLSWYLHKPGKAPQLLIYNRFSGVPDRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKVEIK,,3,jain2017_pnas
ipilimumab,QVQLVESGGGVVQPGRSLRLSCAASMHWVRQAPGKGLEWVTFYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIYYCWGQGTLVTVSSEIVLTQSPGTLSLSPGERATLSCRASLAWYQQKPGQAPRLLIYSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCFGQGTKVEIK,0.0,0,jain2017_pnas
ixekizumab,QVQLVQSGAEVKKPGSSVKVSCKASIHWVRQAPGQGLEWMGVDYNQRFKGRVTITADESTSTAYMELSSLRSEDTAVYYCWGQGTLVTVSSDIVMTQTPLSLSVTPGQPASISCRSSLHWYLQKPGQSPQLLIYNRFIGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFGQGTKLEIK,1.0,6,jain2017_pnas
lampalizumab,EVQLVQSGPELKKPGASVKVSCKASMNWVRQAPGQGLEWMGWTYADDFKGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCWGQGTLVTVSSDIQVTQSPSSLSASVGDRVTITCITSMNWYQQKPGKVPKLLISTLRPGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
lebrikizumab,QVTLRESGPALVKPTQTLTLTCTVSVNWIRQPPGKALEWLAMVYNSALKSRLTISKDTSKNQVVLTMTNMDPVDTATYYCWGQGSLVTVSSDIVMTQSPDSLSVSLGERATINCRASMHWYQQKPGQPPKLLIYNLESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCFGGGTKVEIK,0.0,0,jain2017_pnas
lenzilumab,QVQLVQSGAEVKKPGASVKVSCKASIHWVRQAPGQRLEWMGWKYSQKFQGRVTITRDTSASTAYMELSSLRSEDTAVYYCWGQGTLVTVSSEIVLTQSPATLSVSPGERATLSCRASVAWYQQKPGQAPRVLIYSRATGITDRFSGSGSGTDFTLTISRLEPEDFAVYYCFGGGTKVEIK,1.0,6,jain2017_pnas
lintuzumab,QVQLVQSGAEVKKPGSSVKVSCKASMHWVRQAPGQGLEWIGYGYNQKFKSKATITADESTNTAYMELSSLRSEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRASMNWFQQKPGKAPKLLIYNQGSGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
lirilumab,QVQLVQSGAEVKKPGSSVKVSCKASISWVRQAPGQGLEWMGGNYAQKFQGRVTITADESTSTAYMELSSLRSDDTAVYYCWGQGTTVTVSSEIVLTQSPVTLSLSPGERATLSCRASLAWYQQKPGQAPRLLIYNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCFGQGTKLEIK,0.0,0,jain2017_pnas
lumiliximab,EVQLVESGGGLAKPGGSLRLSCAASMDWVRQAPGQGLEWVSRWYADSVKGRFTISRENANNTLFLQMNSLRAEDTAVYYCWGQGVLVTVSSDIQMTQSPSSLSASVGDRVTITCRASLNWYQQKPGKAPKLLIYSLQSGVPSRFSGSGSGTEFTLTVSSLQPEDFATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
matuzumab,QVQLVQSGAEVKKPGASVKVSCKASMHWVRQAPGQGLEWIGENYNEKFKSKATMTVDTSTNTAYMELSSLRSEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCSASMYWYQQKPGKAPKLLIYNLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
mavrilimumab,QVQLVQSGAEVKKPGASVKVSCKVSIHWVRQAPGKGLEWMGGVYAQRFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCWGQGTMVTVSSQSVLTQPPSVSGAPGQRVTISCTGSVSWYQQLPGTAPKLLIYKRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCFGGGTKLTVL,0.0,0,jain2017_pnas
mepolizumab,QVTLRESGPALVKPTQTLTLTCTVSVHWVRQPPGKGLEWLGVDYNSALMSRLSISKDTSRNQVVLTMTNMDPVDTATYYCWGRGTPVTVSSDIVMTQSPDSLAVSLGERATINCKSSLAWYQQKPGQPPKLLIYTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCFGGGTKLEIK,0.0,0,jain2017_pnas
mogamulizumab,EVQLVESGGDLVQPGRSLRLSCAASMSWVRQAPGKGLEWVATYYPDSVKGRFTISRDNAKNSLYLQMNSLRVEDTALYYCWGQGTLVTVSSDVLMTQSPLSLPVTPGEPASISCRSSLEWYLQKPGQSPQLLIYNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFGQGTKVEIK,0.0,0,jain2017_pnas
motavizumab,QVTLRESGPALVKPTQTLTLTCTFSVGWIRQPPGKALEWLADHYNPSLKDRLTISKDTSKNQVVLKVTNMDPADTATYYCWGQGTTVTVSSDIQMTQSPSTLSASVGDRVTITCSASMHWYQQKPGKAPKLLIYKLASGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCFGGGTKVEIK,,1,jain2017_pnas
muromonab,QVQLQQSGAELARPGASVKMSCKASMHWVKQRPGQGLEWIGYNYNQKFKDKATLTTDKSSSTAYMQLSSLTSEDSAVYYCWGQGTTLTVSSQIVLTQSPAIMSASPGEKVTMTCSASMNWYQQKSGTSPKRWIYKLASGVPAHFRGSGSGTSYSLTISGMEAEDAATYYCFGSGTKLEIK,0.0,0,jain2017_pnas
natalizumab,QVQLVQSGAEVKKPGASVKVSCKASIHWVRQAPGQRLEWMGRKYDPKFQGRVTITADTSASTAYMELSSLRSEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCKTSMAWYQQTPGKAPRLLIHALQPGIPSRFSGSGSGRDYTFTISSLQPEDIATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
necitumumab,QVQLQESGPGLVKPSQTLSLTCTVSWSWIRQPPGKGLEWIGYDYNPSLKSRVTMSVDTSKNQFSLKVNSVTAADTAVYYCWGQGTLVTVSSEIVMTQSPATLSLSPGERATLSCRASLAWYQQKPGQAPRLLIYNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCFGGGTKAEIK,0.0,0,jain2017_pnas
nimotuzumab,QVQLQQSGAEVKKPGSSVKVSCKASIYWVRQAPGQGLEWIGGNFNEKFKTRVTITADESSTTAYMELSSLRSEDTAFYFCWGQGTTVTVSSDIQMTQSPSSLSASVGDRVTITCRSSLDWYQQTPGKAPKLLIYNRFSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCFGQGTKLQIT,0.0,0,jain2017_pnas
nivolumab,QVQLVESGGGVVQPGRSLRLDCKASMHWVRQAPGKGLEWVAVYYADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCWGQGTLVTVSSEIVLTQSPATLSLSPGERATLSCRASLAWYQQKPGQAPRLLIYNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCFGQGTKVEIK,0.0,0,jain2017_pnas
obinutuzumab,QVQLVQSGAEVKKPGSSVKVSCKASINWVRQAPGQGLEWMGRDYNGKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCWGQGTLVTVSSDIVMTQTPLSLPVTPGEPASISCRSSLYWYLQKPGQSPQLLIYNLVSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFGGGTKVEIK,0.0,0,jain2017_pnas
ocrelizumab,EVQLVESGGGLVQPGGSLRLSCAASMHWVRQAPGKGLEWVGASYNQKFKGRFTISVDKSKNTLYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRASMHWYQQKPGKAPKPLIYNLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
ofatumumab,EVQLVESGGGLVQPGRSLRLSCAASMHWVRQAPGKGLEWVSTGYADSVKGRFTISRDNAKKSLYLQMNSLRAEDTALYYCWGQGTTVTVSSEIVLTQSPATLSLSPGERATLSCRASLAWYQQKPGQAPRLLIYNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCFGQGTRLEIK,0.0,0,jain2017_pnas
olaratumab,QLQLQESGPGLVKPSETLSLTCTVSWGWLRQSPGKGLEWIGSYYNPSLRSRLTISVDTSKNQFSLMLSSVTAADTAVYYCWDQGTLVTVSSEIVLTQSPATLSLSPGERATLSCRASLAWYQQKPGQAPRLLIYNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCFGQGTKVEIK,0.0,0,jain2017_pnas
olokizumab,EVQLVESGGGLVQPGGSLRLSCAASMNWVRQAPGKGLEWVAQYYAESLEGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCQASLSWYQQKPGKAPKLLIYNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKLEIK,0.0,0,jain2017_pnas
omalizumab,EVQLVESGGGLVQPGGSLRLSCAVSWNWIRQAPGKGLEWVASNYNPSLKGRITISRDDSKNTFYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIQLTQSPSSLSASVGDRVTITCRASMNWYQQKPGKAPKLLIYYLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
onartuzumab,EVQLVESGGGLVQPGGSLRLSCAASLHWVRQAPGKGLEWVGMRFNPNFKDRFTISADTSKNTAYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCKSSLAWYQQKPGKAPKLLIYTRESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
otelixizumab,EVQLLESGGGLVQPGGSLRLSCAASMAWVRQAPGKGLEWVSTYYRDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIQLTQPNSVSTSLGSTVKLSCTLSVHWYQLYEGRSPTTMIYKRPDGVPDRFSGSIDRSSNSAFLTIHNVAIEDEAIYFCFGGGTKLTVL,0.0,0,jain2017_pnas
otlertuzumab,EVQLVQSGAEVKKPGESLKISCKGSMNWVRQMPGKGLEWMGNTYNRKFKGQVTISADKSISTAYLQWSSLKASDTAMYYCWGQGTLVTVSSEIVLTQSPATLSLSPGERATLSCRASLAWYQQKPGQAPRLLIYTLAEGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCFGQGTKVEIK,0.0,0,jain2017_pnas
ozanezumab,QVQLVQSGAEVKKPGASVKVSCKASMHWVRQAPGQGLEWIGNNYNEKFKSKATMTRDTSTSTAYMELSSLRSEDTAVYYCWGQGTLVTVSSDIVMTQSPLSNPVTLGQPVSISCRSSLNWFLQRPGQSPQLLIYTRASGVPDRFSGGGSGTDFTLKISRVEAEDVGVYYCFGQGTKLEIK,,3,jain2017_pnas
palivizumab,QVTLRESGPALVKPTQTLTLTCTFSVGWIRQPPGKALEWLADDYNPSLKSRLTISKDTSKNQVVLKVTNMDPADTATYYCWGAGTTVTVSSDIQMTQSPSTLSASVGDRVTITCKCQMHWYQQKPGKAPKLLIYKLASGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCFGGGTKLEIK,0.0,0,jain2017_pnas
panitumumab,QVQLQESGPGLVKPSETLSLTCTVSWTWIRQSPGKGLEWIGHNYNPSLKSRLTISIDTSKTQFSLKLSSVTAADTAIYYCWGQGTMVTVSSDIQMTQSPSSLSASVGDRVTITCQASLNWYQQKPGKAPKLLIYNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYFCFGGGTKVEIK,0.0,0,jain2017_pnas
panobacumab,EEQVVESGGGFVQPGGSLRLSCAASMHWVRQAPGKGLVWVSRYYADSVKGRFTISRDNARNTLYLQMNSLRAEDTAVYYCWGQGTMVTVSSDVVMTQSPLSLPVTLGQPASISCRSSLNWFQQRPGQSPRRLIYNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFGGGTKVEIK,0.0,0,jain2017_pnas
parsatuzumab,EVQLVESGGGLVQPGGSLRLSCAASMNWVRQAPGKGLEWVGDHYNQKFKGRFTISRDKSKNTAYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRTSLHWYQQKPGKAPKLLIYNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKVEIK,1.0,6,jain2017_pnas
patritumab,QVQLQQWGAGLLKPSETLSLTCAVYWSWIRQPPGKGLEWIGENYNPSLKSRVTISVETSKNQFSLKLSSVTAADTAVYYCWGRGTLVTVSSDIEMTQSPDSLAVSLGERATINCRSSLAWYQQNPGQPPKLLIYTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCFGQGTKVEIK,1.0,4,jain2017_pnas
pembrolizumab,QVQLVQSGVEVKKPGASVKVSCKASMYWVRQAPGQGLEWMGGNFNEKFKNRVTLTTDSSTTTAYMELKSLQFDDTAVYYCWGQGTTVTVSSEIVLTQSPATLSLSPGERATLSCRASLHWYQQKPGQAPRLLIYYLESGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCFGGGTKVEIK,0.0,0,jain2017_pnas
pertuzumab,EVQLVESGGGLVQPGGSLRLSCAASMDWVRQAPGKGLEWVADIYNQRFKGRFTLSVDRSKNTLYLQMNSLRAEDTAVYYCYWGQGTLVTVSDIQMTQSPSSLSASVGDRVTITCKASVAWYQQKPGKAPKLLIYYRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
pinatuzumab,EVQLVESGGGLVQPGGSLRLSCAASMNWVRQAPGKGLEWVGRNYSGKFKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRSSLEWYQQKPGKAPKLLIYNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
polatuzumab,EVQLVESGGGLVQPGGSLRLSCAASIEWVRQAPGKGLEWIGENYNEIFKGRATFSADTSKNTAYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIQLTQSPSSLSASVGDRVTITCKASLNWYQQKPGKAPKLLIYNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
ponezumab,QVQLVQSGAEVKKPGASVKVSCKASIHWVRQAPGQGLEWMGRKYAPRLQDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCWGQGTTVTVSSDVVMTQSPLSLPVTLGQPASISCKSSLNWFQQRPGQSPRRLIYRLDPGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFGQGTRLEIK,1.0,4,jain2017_pnas
radretumab,EVQLLESGGGLVQPGGSLRLSCAASMSWVRQAPGKGLEWVSSYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCWGQGTLVTVSSEIVLTQSPGTLSLSPGERATLSCRASLAWYQQKPGQAPRLLIYSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCFGQGTKVEIK,0.0,0,jain2017_pnas
ramucirumab,EVQLVQSGGGLVKPGGSLRLSCAASMNWVRQAPGKGLEWVSSYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCWGQGTMVTVSSDIQMTQSPSSVSASIGDRVTITCRASLGWYQQKPGKAPKLLIYNLDTGVPSRFSGSGSGTYFTLTISSLQAEDFAVYFCFGGGTKVDIK,0.0,0,jain2017_pnas
ranibizumab,EVQLVESGGGLVQPGGSLRLSCAASMNWVRQAPGKGLEWVGWTYAADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIQLTQSPSSLSASVGDRVTITCSASLNWYQQKPGKAPKVLIYSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKVEIK,,1,jain2017_pnas
reslizumab,EVQLVESGGGLVQPGGSLRLSCAVSVNWIRQAPGKGLEWVGLDYNSAIKSRFTISRDTSKSTVYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCLASLAWYQQKPGKAPKLLIYSLQTGVPSRFSGSGSATDYTLTISSLQPEDFATYYCFGQGTKVEVK,0.0,0,jain2017_pnas
rilotumumab,QVQLQESGPGLVKPSETLSLTCTVSWSWIRQPPGKGLEWIGYNYNPSLKSRVTISVDTSKNQFSLKLNSVTAADTAVYYCWGQGTLVTVSSEIVMTQSPATLSVSPGERATLSCRASLAWYRQKPGQAPRLLIYTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCFGQGTRLEIK,0.0,0,jain2017_pnas
rituximab,QVQLQQPGAELVKPGASVKMSCKASMHWVKQTPGRGLEWIGASYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCWGAGTTVTVSAQIVLSQSPAILSASPGEKVTMTCRASIHWFQQKPGSSPKPWIYNLASGVPVRFSGSGSGTSYSLTISRVEAEDAATYYCFGGGTKLEIK,0.0,0,jain2017_pnas
robatumumab,EVQLVQSGGGLVKPGGSLRLSCAASMHWVRQAPGKGLEWISVYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCWGQGTTVTVSSEIVLTQSPGTLSVSPGERATLSCRASLHWYQQKPGQAPRLLIKQSLSGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCFGQGTKVEIK,1.0,4,jain2017_pnas
romosozumab,EVQLVQSGAEVKKPGASVKVSCKASMHWVRQAPGQGLEWMGEGYNQKFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCWGQGTTVTVSSDIQMTQSPSSLSASVGDRVTITCRASLNWYQQKPGKAPKLLIYRLLSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGGGTKVEIK,0.0,0,jain2017_pnas
sarilumab,EVQLVESGGGLVQPGRSLRLSCAASMHWVRQAPGKGLEWVSGGYADSVKGRFTISRDNAENSLFLQMNGLRAEDTALYYCWGQGTMVTVSSDIQMTQSPSSVSASVGDRVTITCRASLAWYQQKPGKAPKLLIYSLESGVPSRFSGSGSGTDFTLTISSLQPEDFASYYCFGQGTKLEIK,0.0,0,jain2017_pnas
secukinumab,EVQLVESGGGLVQPGGSLRLSCAASMNWVRQAPGKGLEWVAAYYVGSVKGRFTISRDNAKNSLYLQMNSLRVEDTAVYYCWGRGTLVTVSSEIVLTQSPGTLSLSPGERATLSCRASLAWYQQKPGQAPRLLIYSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCFGQGTRLEIK,0.0,0,jain2017_pnas
seribantumab,EVQLLESGGGLVQPGGSLRLSCAASMAWVRQAPGKGLEWVSSLYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCWGQGTLVTVSSQSALTQPASVSGSPGQSITISCTGTVSWYQQHPGKAPKLIIYQRPSGVSNRFSGSKSGNTASLTISGLQTEDEADYYCFGGGTKVTVL,0.0,0,jain2017_pnas
sifalimumab,QVQLVQSGAEVKKPGASVKVSCKASISWVRQAPGQGLEWMGWNYAQKFQGRVTMTTDTSTSTAYLELRSLRSDDTAVYYCWGQGTLVTVSSEIVLTQSPGTLSLSPGERATLSCRASLAWYQQKPGQAPRLLIYSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCFGQGTKVEIK,,3,jain2017_pnas
siltuximab,EVQLVESGGKLLKPGGSLKLSCAASMSWFRQSPEKRLEWVAEYYPDTVTGRFTISRDNAKNTLYLEMSSLRSEDTAMYYCWGQGTSVTVSSQIVLIQSPAIMSASPGEKVTMTCSASMYWYQQKPGSSPRLLIYNLASGVPVRFSGSGSGTSYSLTISRMEAEDAATYYCFGGGTKLEIK,0.0,0,jain2017_pnas
simtuzumab,QVQLVQSGAEVKKPGASVKVSCKASIEWVRQAPGQGLEWIGVNYNEKFKGRATITADKSTSTAYMELSSLRSEDTAVYFCWGQGTTVTVSSDIVMTQTPLSLSVTPGQPASISCRSSLYWFLQKPGQSPQFLIYNLASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFGGGTKVEIK,1.0,6,jain2017_pnas
sirukumab,EVQLVESGGGLVQPGGSLRLSCAASMSWVRQAPGKGLEWVAKYYSDTVTGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCWGQGTTVTVSSEIVLTQSPATLSLSPGERATLSCSASMYWYQQKPGQAPRLLIYNLASGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCFGGGTKVEIK,1.0,5,jain2017_pnas
tabalumab,QVQLQQWGAGLLKPSETLSLTCAVYWSWIRQPPGKGLEWIGENYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCWGQGTLVTVSSEIVLTQSPATLSLSPGERATLSCRASLAWYQQKPGQAPRLLIYNRATGIPARFSGSGSGTDSTLTISSLEPEDFAVYYCFGQGTKVEIK,0.0,0,jain2017_pnas
tanezumab,QVQLQESGPGLVKPSETLSLTCTVSLNWIRQPPGKGLEWIGIDYNSAVKSRVTISKDTSKNQFSLKLSSVTAADTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRASLNWYQQKPGKAPKLLIYRFHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCFGQGTKLEIK,,1,jain2017_pnas
teplizumab,QVQLVQSGGGVVQPGRSLRLSCKASMHWVRQAPGKGLEWIGYNYNQKVKDRFTISRDNSKNTAFLQMDSLRPEDTGVYFCWGQGTPVTVSSDIQMTQSPSSLSASVGDRVTITCSASMNWYQQTPGKAPKRWIYKLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCFGQGTKLQIT,,2,jain2017_pnas
tigatuzumab,EVQLVESGGGLVQPGGSLRLSCAASMSWVRQAPGKGLEWVATYYPDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCKASVAWYQQKPGKAPKLLIYTRHTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
tildrakizumab,QVQLVQSGAEVKKPGASVKVSCKASMTWVRQAPGQGLEWMGQDYNEKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRTSLAWYQQKPGKAPKLLIYTLAEGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
tocilizumab,QVQLQESGPGLVRPSQTLSLTCTVSWSWVRQPPGRGLEWIGYTYNPSLKSRVTMLRDTSKNQFSLRLSSVTAADTAVYYCWGQGSLVTVSSDIQMTQSPSSLSASVGDRVTITCRASLNWYQQKPGKAPKLLIYRLHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
tovetumab,QVQLVESGGGLVKPGGSLRLSCAASMNWIRQAPGKGLEWVSYYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCWGQGTTVTVSSDIQMTQSPSSLSASVGDRVSITCRPSINWYQQKPGKAPKLLIHSLVGGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTRLEMK,0.0,0,jain2017_pnas
tralokinumab,QVQLVQSGAEVKKPGASVKVSCKASLSWVRQAPGQGLEWMGWNYGQEFQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCWGRGTLVTVSSSYVLTQPPSVSVAPGKTARITCGGNVHWYQQKPGQAPVLVIYDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCFGGGTKLTVL,0.0,0,jain2017_pnas
trastuzumab,EVQLVESGGGLVQPGGSLRLSCAASIHWVRQAPGKGLEWVARRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRASVAWYQQKPGKAPKLLIYFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCFGQGTKVEIK,0.0,0,jain2017_pnas
tremelimumab,QVQLVESGGGVVQPGRSLRLSCAASMHWVRQAPGKGLEWVAVYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCWGQGTTVTVSSDIQMTQSPSSLSASVGDRVTITCRASLDWYQQKPGKAPKLLIYSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGPGTKVEIK,0.0,0,jain2017_pnas
urelumab,QVQLQQWGAGLLKPSETLSLTCAVYWSWIRQSPEKGLEWIGETYNPSLESRVTISVDTSKNQFSLKLSSVTAADTAVYYCWGRGTLVTVSSEIVLTQSPATLSLSPGERATLSCRASLAWYQQKPGQAPRLLIYNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCFGGGTKVEIK,0.0,0,jain2017_pnas
ustekinumab,EVQLVQSGAEVKKPGESLKISCKGSLGWVRQMPGKGLDWIGIRYSPSFQGQVTMSVDKSITTAYLQWNSLKASDTAMYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCRASLAWYQQKPEKAPKSLIYSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKLEIK,,3,jain2017_pnas
vedolizumab,QVQLVQSGAEVKKPGASVKVSCKGSMHWVRQAPGQRLEWIGENYNQKFKGRVTLTVDISASTAYMELSSLRSEDTAVYYCWGQGTLVTVSSDVVMTQSPLSLPVTPGEPASISCRSSLSWYLQKPGQSPQLLIYNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFGQGTKVEIK,0.0,0,jain2017_pnas
veltuzumab,QVQLQQSGAEVKKPGSSVKVSCKASMHWVKQAPGQGLEWIGASYNQKFKGKATLTADESTNTAYMELSSLRSEDTAFYYCWGQGTTVTVSSDIQLTQSPSSLSASVGDRVTMTCRASIHWFQQKPGKAPKPWIYNLASGVPVRFSGSGSGTDYTFTISSLQPEDIATYYCFGGGTKLEIK,0.0,0,jain2017_pnas
visilizumab,QVQLVQSGAEVKKPGASVKVSCKASMHWVRQAPGQGLEWMGYHYNQKLKDKATLTADKSASTAYMELSSLRSEDTAVYYCWGQGTLVTVSSDIQMTQSPSSLSASVGDRVTITCSASMNWYQQKPGKAPKRLIYKLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGGGTKVEIK,,3,jain2017_pnas
zalutumumab,QVQLVESGGGVVQPGRSLRLSCAASMHWVRQAPGKGLEWVAVYYGDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCWGQGTLVTVSSAIQLTQSPSSLSASVGDRVTITCRASLVWYQQKPGKAPKLLIYSLESGVPSRFSGSESGTDFTLTISSLQPEDFATYYCFGGGTKVEIK,,1,jain2017_pnas
zanolimumab,QVQLQQWGAGLLKPSETLSLTCAVYWSWIRQPPGKGLEWIGENYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCWGQGTLVTVSSDIQMTQSPSSVSASVGDRVTITCRASLAWYQHKPGKAPKLLIYSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFGQGTKLEIK,0.0,0,jain2017_pnas
